Skip to main content

Ziprasidone Hcl

FDA recalls

1 row

DateCompany and reasonClass
May 30, 2023The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Labeling: Label Mix-up: Unit Dose cartons labeled as Ziprasidone Hydrochloride Capsules, 20 mg were found to contain blister packages labeled as and containing Dronabinol Capsules, USP, 2.5 mg.
Class I · Terminated

← Back to Ziprasidone Hcl

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).